TRIFAST PLC (TRI) — Investment Research Note

Executive summary

Trifast is a UK-listed international specialist in the design, engineering, manufacture and distribution of high-quality engineered fastenings and Category 'C' components sold principally to global OEM assembly industries (Automotive c.35-40% of revenue, Smart Infrastructure 17%, Medical Equipment, general industrial). The operating trajectory over the five-year window is a story of a strategic reset: revenue peaked at £244m in FY23, has since contracted to £208m in FY26 as management deliberately exited low-margin business, while underlying EBIT margin has recovered from 4.9% (FY23) to 7.9% (FY26) under the "Recover, Rebuild, Resilience" strategy 2026-07 final results. The single most important valuation point today is whether investors believe management's stated path from 7.9% to a >10% underlying EBIT margin on a stabilising revenue base — the current share price already discounts partial success, so the shares look fair-to-modestly-cheap on underlying earnings but statutory results remain very noisy.

Fair value estimate

Fair value range: 75p – 105p per share, implying market cap £101m – £142m

Methodology: blended multiple of forward underlying EBIT and PE.

• FY26 underlying diluted EPS: 6.46p 2026-07 final results. At 12–15x PE this implies 78p – 97p.
• FY26 underlying EBIT £16.5m; EV/EBIT of 8-10x → £132m – £165m EV; subtract £16m adjusted net debt → 86p – 110p per share.
• Bull case (achieving 10%+ EBIT margin on £220m revenue → £22m EBIT × 9x) = £183m EV = ~130p; discounted for execution risk.

Midpoint 90p / £122m mcap vs latest disclosed £116.7m. Absolute upside vs current 87p: c. +3.4% (range −14% to +21%).

The market is pricing the business at roughly fair value. Not a value opportunity, not overpriced.

Sector context

Confirmed: Industrials / Industrial Goods and Services. Trifast is a small-cap fastener distributor-manufacturer.

• Quality: below sector average — statutory earnings are heavily distorted by separately-disclosed items, ERP restatements, and impairments; ROCE 8.5% is modest for an industrial specialist 2026-07 final results.
• Growth: below sector — revenue declining two consecutive years; management guiding to a "return to profitable top-line growth".
• Leverage: better than sector average — adjusted net debt 0.75x EBITDA is comfortably low.
• Peers: Bufab AB (SE, direct competitor), Fastenal (US, much larger), Diploma PLC (UK specialist distribution). Trifast trades at a discount to Bufab and a very steep discount to Fastenal/Diploma reflecting scale, growth and quality gaps.

Investment thesis (3 bullets)

1. Margin recovery genuinely in progress: underlying EBIT margin has expanded 300bps in two years (4.9% FY23 → 7.9% FY26) despite a 15% revenue decline, supported by pricing discipline, portfolio exit of low-margin accounts, Malaysia manufacturing exit and Hungary shared services set-up — with clear line of sight to the >10% medium-term target 2026-07 final results.
2. Solid balance sheet enables self-funded transition: adjusted leverage improved to 0.75x, £70m RCF (drawn £28.6m) plus £50m UKEF facility, cash conversion 94% of underlying EBITDA and dividend nudged up to 1.90p — the business can execute the turnaround without equity risk 2026-07 final results.
3. Modest, indirect AI-adjacent exposure: Smart Infrastructure is now 17% of the portfolio (targeted 30% by FY30) with growth in "data connectivity", HVAC, power distribution and data-centre rollouts, plus North America growing (+6% CER) driven by Smart Infrastructure and Medical 2026-07 final results; 2025-11 half-year. Note this is a peripheral, not core, thesis point.

Key risks (3 bullets)

1. Revenue re-acceleration remains unproven: FY26 revenue declined 7.3% CER despite management's "strongest commercial pipeline since strategy implementation"; if the top-line does not stabilise in FY27, operating leverage works in reverse and the 10% margin target slips 2026-07 final results; 2026-04 trading statement — FY27 revenue to be reduced c.£8m by Malaysia exit and Middle East disruption.
2. Statutory earnings quality is poor: FY26 statutory PBT collapsed to £0.1m from £4.9m due to £12.3m of separately-disclosed items including £6m Project Ignite SaaS costs that had to be expensed under IFRIC guidance (prior-year restated £5.4m off retained earnings), £1.4m Malaysia write-off, £0.9m impairments, ongoing facilitation-payment fraud items — noise persistently muddies GAAP results 2026-07 final results.
3. Cyclical automotive exposure and macro sensitivity: Automotive weakness (UK OEM cyber-attack, EV subsidy removals, Chinese EV competition eroding Asia margin by 620bps in FY26), US tariffs, Middle East conflict and Asia demand softness are all live risks — Asia underlying EBIT fell 42% in FY26 2026-07 final results.

Operating leverage

Operating leverage at Trifast is moderate, not dramatic. The cost base is dominated by materials/cost of sales (£146m of £208m, i.e. 70% of revenue) with gross margin at 30% 2026-07 final results. Central overheads run around £4.7-6.8m; payroll totalled £45.8m across ~1,020 average headcount, and the Group has undertaken meaningful fixed-cost right-sizing. The most visible margin recovery has come from mix/pricing (170bps gross margin expansion in FY26) rather than pure volume gearing. Management guides to a 220bps further EBIT margin expansion (from 7.9% to >10%), implying that on stable £210m revenue, EBIT would rise from £16.5m to £21m+ — a 25%+ profit uplift on flat revenue. However, if revenue grows 10-20% above current levels (to £230-250m), incremental gross margin drop-through at 30-35% suggests EBIT could plausibly reach £25-30m — meaningful, but not a "multiples of profit" outcome from a modest revenue beat. Genuine capacity-constrained inflection is not visible; this is a scale/mix story, not a network-effect/software-style operating leverage story. Fixed-cost sites include TR VIC (Italy) manufacturing and the UK NDC, with capacity headroom available 2025-11 half-year; 2026-07 final results.

Value-trap signals

• Two consecutive years of revenue decline (-4.4% FY25, -6.7% FY26) with FY27 also expected to face headwinds from Malaysia exit and Middle East.
• Statutory PBT collapsed to £0.1m in FY26; recurring "separately disclosed items" have been material every year (£12.3m in FY26, £5.5m FY25, £7.3m FY24).
• Historical restatement of prior-year retained earnings (£5.4m SaaS/ERP costs reversed under IFRIC).
• Small recurring fraud/facilitation payment items (£0.2-0.4m each year) — not large but a governance flag worth watching.
• ROCE still only 8.5%, well below cost of capital.
• Dividend cover thin on statutory earnings (statutory diluted EPS was -0.73p vs 1.90p dividend); relies on underlying earnings.
• Discount rate/goodwill sensitivity (TR VIC Italy) has been repeatedly flagged in prior filings.

Earnings vs. expectations

• FY26 final results (Jul-26): Consensus revenue £207m, underlying EBIT £16.0m, PBT £11.7m; delivered £208.4m / £16.5m / £12.3m — modest beat 2026-07 final results.
• FY26 pre-close (Apr-26): guided c.£207m revenue and c.£16m EBIT (vs earlier consensus £214m/£16m) — revenue miss vs prior consensus, EBIT in line.
• HY26 (Nov-25): revenue -7% but EBIT margin held; guided full year unchanged — met.
• FY25 (Jul-25): prior consensus underlying EBIT £14.6m; delivered £14.9m AER — small beat.
• Jan-24 profit warning: FY24 revenue cut from consensus £254m to c.£230m and EBIT margin to c.5% — a significant miss driven by destocking/weak demand.

Pattern: One material profit warning (Jan 2024) followed by two years of hitting or slightly beating a reset baseline. Management is credible on the reset but not yet reliably beating consensus.

Conviction

Conviction: 3 (moderate). Anchors: (1) audited, transparent underlying financials with detailed segmental disclosure and clear reconciliation of underlying vs statutory; (2) low leverage and cash generation reduce tail risk; (3) multiple valuation methods converge in a similar 75-105p range. Limiters: (1) revenue trajectory into FY27 is unclear and highly dependent on unproven pipeline conversion; (2) recurring separately-disclosed items make statutory earnings hard to trust — an accounting reset (prior-year restatement) occurred within the window.